Journal of International Oncology››2013,Vol. 40››Issue (5): 332-335.

Previous ArticlesNext Articles

Myloied derived suppressor cells and cancer

SHAO Li-Juan, WANG Ruo-Yu, WU Ting-Ting, ZHAO Yong

  1. Department of Oncology, Afflicated Zhongshan Hospital of Dalian University, Dalian 116001, China
  • Online:2013-05-08Published:2013-05-15
  • Contact:ZHAO Yong E-mail:zhaoy@ioz.ac.cn

Abstract:Myeloid derived suppressor cells(MDSCs)are a subpopulation of immunosuppressive innate immune cells derived from bone marrow stem cells, which negatively regulate immune response in tumor progression. MDSCs have a powerful suppressive function and significant heterogeneity. They can modulate innate and adaptive immune responses through a variety of mechanisms to promote the development of tumor, and also facilitate angiogenesis and metastasis of tumor via non immunologic mechanisms.In recent years, as increasingly mature research for the differentiation, proliferation and suppressive function of MDSCs, the derived researches of MDSC-targeted tumor immunotherapy will finally contribute to increasing the efficiency of vaccine and tumor therapy in the future.

Key words:Neoplasms,Myeloid cells,Myloied derived suppressor cells,Targeted therapy